| UniProt ID | KPCD3_HUMAN | |
|---|---|---|
| UniProt AC | O94806 | |
| Protein Name | Serine/threonine-protein kinase D3 | |
| Gene Name | PRKD3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 890 | |
| Subcellular Localization | Cytoplasm . Membrane . Translocation to the cell membrane is required for kinase activation. | |
| Protein Description | Converts transient diacylglycerol (DAG) signals into prolonged physiological effects, downstream of PKC. Involved in resistance to oxidative stress (By similarity).. | |
| Protein Sequence | MSANNSPPSAQKSVLPTAIPAVLPAASPCSSPKTGLSARLSNGSFSAPSLTNSRGSVHTVSFLLQIGLTRESVTIEAQELSLSAVKDLVCSIVYQKFPECGFFGMYDKILLFRHDMNSENILQLITSADEIHEGDLVEVVLSALATVEDFQIRPHTLYVHSYKAPTFCDYCGEMLWGLVRQGLKCEGCGLNYHKRCAFKIPNNCSGVRKRRLSNVSLPGPGLSVPRPLQPEYVALPSEESHVHQEPSKRIPSWSGRPIWMEKMVMCRVKVPHTFAVHSYTRPTICQYCKRLLKGLFRQGMQCKDCKFNCHKRCASKVPRDCLGEVTFNGEPSSLGTDTDIPMDIDNNDINSDSSRGLDDTEEPSPPEDKMFFLDPSDLDVERDEEAVKTISPSTSNNIPLMRVVQSIKHTKRKSSTMVKEGWMVHYTSRDNLRKRHYWRLDSKCLTLFQNESGSKYYKEIPLSEILRISSPRDFTNISQGSNPHCFEIITDTMVYFVGENNGDSSHNPVLAATGVGLDVAQSWEKAIRQALMPVTPQASVCTSPGQGKDHKDLSTSISVSNCQIQENVDISTVYQIFADEVLGSGQFGIVYGGKHRKTGRDVAIKVIDKMRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKSRLPERITKFMVTQILVALRNLHFKNIVHCDLKPENVLLASAEPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRSKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWREISGEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLREFETRIGERYITHESDDARWEIHAYTHNLVYPKHFIMAPNPDDMEEDP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSANNSPPS ------CCCCCCCCH | 39.44 | 29255136 | |
| 6 | Phosphorylation | --MSANNSPPSAQKS --CCCCCCCCHHHHC | 37.69 | 29255136 | |
| 9 | Phosphorylation | SANNSPPSAQKSVLP CCCCCCCHHHHCCCC | 46.87 | 30177828 | |
| 13 | Phosphorylation | SPPSAQKSVLPTAIP CCCHHHHCCCCCCHH | 19.46 | 23403867 | |
| 17 | Phosphorylation | AQKSVLPTAIPAVLP HHHCCCCCCHHHHCC | 32.81 | 20068231 | |
| 27 | Phosphorylation | PAVLPAASPCSSPKT HHHCCCCCCCCCCCC | 28.66 | 20201521 | |
| 30 | Phosphorylation | LPAASPCSSPKTGLS CCCCCCCCCCCCCCC | 53.73 | 20201521 | |
| 31 | Phosphorylation | PAASPCSSPKTGLSA CCCCCCCCCCCCCCE | 36.81 | 25159151 | |
| 34 | Ubiquitination | SPCSSPKTGLSARLS CCCCCCCCCCCEECC | 46.90 | 21890473 | |
| 34 | Phosphorylation | SPCSSPKTGLSARLS CCCCCCCCCCCEECC | 46.90 | 28450419 | |
| 37 | Phosphorylation | SSPKTGLSARLSNGS CCCCCCCCEECCCCC | 16.82 | 22617229 | |
| 41 | Phosphorylation | TGLSARLSNGSFSAP CCCCEECCCCCCCCC | 33.32 | 22167270 | |
| 44 | Phosphorylation | SARLSNGSFSAPSLT CEECCCCCCCCCCCC | 21.93 | 22167270 | |
| 46 | Phosphorylation | RLSNGSFSAPSLTNS ECCCCCCCCCCCCCC | 40.75 | 30266825 | |
| 49 | Phosphorylation | NGSFSAPSLTNSRGS CCCCCCCCCCCCCCC | 47.76 | 23403867 | |
| 51 | Phosphorylation | SFSAPSLTNSRGSVH CCCCCCCCCCCCCEE | 35.17 | 22167270 | |
| 53 | Phosphorylation | SAPSLTNSRGSVHTV CCCCCCCCCCCEEHH | 32.55 | 22167270 | |
| 120 | Ubiquitination | RHDMNSENILQLITS ECCCCCHHHHHHHHC | 39.84 | 21890473 | |
| 166 | Phosphorylation | VHSYKAPTFCDYCGE EEECCCCCHHHHHHH | 41.58 | 30387612 | |
| 170 | Phosphorylation | KAPTFCDYCGEMLWG CCCCHHHHHHHHHHH | 11.97 | 30387612 | |
| 189 | Ubiquitination | GLKCEGCGLNYHKRC CCCCCCCCCCCCCCC | 28.02 | 21890473 | |
| 213 | Phosphorylation | GVRKRRLSNVSLPGP CCCCCCCCCCCCCCC | 33.12 | 30266825 | |
| 216 | Phosphorylation | KRRLSNVSLPGPGLS CCCCCCCCCCCCCCC | 32.85 | 29255136 | |
| 223 | Phosphorylation | SLPGPGLSVPRPLQP CCCCCCCCCCCCCCC | 35.67 | 18691976 | |
| 232 | Phosphorylation | PRPLQPEYVALPSEE CCCCCCCEEECCCCC | 9.56 | 28796482 | |
| 237 | Phosphorylation | PEYVALPSEESHVHQ CCEEECCCCCCCCCC | 55.64 | 18691976 | |
| 240 | Phosphorylation | VALPSEESHVHQEPS EECCCCCCCCCCCCC | 27.10 | 27642862 | |
| 247 | Phosphorylation | SHVHQEPSKRIPSWS CCCCCCCCCCCCCCC | 33.54 | 18691976 | |
| 252 | Phosphorylation | EPSKRIPSWSGRPIW CCCCCCCCCCCCCEE | 31.35 | 22617229 | |
| 254 | Phosphorylation | SKRIPSWSGRPIWME CCCCCCCCCCCEECE | 29.30 | 23403867 | |
| 293 | Ubiquitination | QYCKRLLKGLFRQGM HHHHHHHHHHHHCCC | 59.15 | 21890473 | |
| 315 | Phosphorylation | NCHKRCASKVPRDCL CCCHHHHCCCCHHHC | 37.50 | 24719451 | |
| 332 | Phosphorylation | VTFNGEPSSLGTDTD EEECCCCCCCCCCCC | 33.61 | 22210691 | |
| 336 | Phosphorylation | GEPSSLGTDTDIPMD CCCCCCCCCCCCCCC | 40.81 | 30576142 | |
| 351 | Phosphorylation | IDNNDINSDSSRGLD CCCCCCCCCCCCCCC | 38.92 | 22210691 | |
| 360 | Phosphorylation | SSRGLDDTEEPSPPE CCCCCCCCCCCCCCC | 41.75 | 21815630 | |
| 364 | Phosphorylation | LDDTEEPSPPEDKMF CCCCCCCCCCCCCCE | 57.26 | 23401153 | |
| 389 | Phosphorylation | RDEEAVKTISPSTSN CCHHHHHHCCCCCCC | 21.79 | 30266825 | |
| 391 | Phosphorylation | EEAVKTISPSTSNNI HHHHHHCCCCCCCCC | 20.30 | 29255136 | |
| 393 | Phosphorylation | AVKTISPSTSNNIPL HHHHCCCCCCCCCCH | 37.36 | 30266825 | |
| 394 | Phosphorylation | VKTISPSTSNNIPLM HHHCCCCCCCCCCHH | 38.57 | 30266825 | |
| 395 | Phosphorylation | KTISPSTSNNIPLMR HHCCCCCCCCCCHHH | 32.01 | 30266825 | |
| 406 | Phosphorylation | PLMRVVQSIKHTKRK CHHHHHHHHHHCCCC | 23.22 | 30576142 | |
| 408 | Ubiquitination | MRVVQSIKHTKRKSS HHHHHHHHHCCCCCC | 50.93 | 29967540 | |
| 414 | Phosphorylation | IKHTKRKSSTMVKEG HHHCCCCCCCCEECC | 34.77 | 19369195 | |
| 415 | Phosphorylation | KHTKRKSSTMVKEGW HHCCCCCCCCEECCE | 24.45 | 22817900 | |
| 426 | Phosphorylation | KEGWMVHYTSRDNLR ECCEEEEEECCCCCH | 8.59 | - | |
| 442 | Phosphorylation | RHYWRLDSKCLTLFQ HEEEEECHHHEEEEE | 29.84 | 23312004 | |
| 446 | Phosphorylation | RLDSKCLTLFQNESG EECHHHEEEEECCCC | 34.69 | 23312004 | |
| 452 | Phosphorylation | LTLFQNESGSKYYKE EEEEECCCCCCEEEE | 56.78 | 28348404 | |
| 455 | Acetylation | FQNESGSKYYKEIPL EECCCCCCEEEECCH | 57.00 | 26051181 | |
| 456 | Phosphorylation | QNESGSKYYKEIPLS ECCCCCCEEEECCHH | 22.82 | 24719451 | |
| 457 | Phosphorylation | NESGSKYYKEIPLSE CCCCCCEEEECCHHH | 13.09 | 29341593 | |
| 463 | Phosphorylation | YYKEIPLSEILRISS EEEECCHHHHHCCCC | 19.75 | 24719451 | |
| 469 | Phosphorylation | LSEILRISSPRDFTN HHHHHCCCCCCCCCC | 28.05 | 23532336 | |
| 470 | Phosphorylation | SEILRISSPRDFTNI HHHHCCCCCCCCCCC | 22.91 | 24719451 | |
| 471 | Ubiquitination | EILRISSPRDFTNIS HHHCCCCCCCCCCCC | 32.82 | 27667366 | |
| 535 | Phosphorylation | RQALMPVTPQASVCT HHHHCCCCCCCCEEC | 12.10 | 25159151 | |
| 539 | Phosphorylation | MPVTPQASVCTSPGQ CCCCCCCCEECCCCC | 16.69 | 25159151 | |
| 542 | Phosphorylation | TPQASVCTSPGQGKD CCCCCEECCCCCCCC | 35.48 | 25159151 | |
| 543 | Phosphorylation | PQASVCTSPGQGKDH CCCCEECCCCCCCCC | 23.16 | 25159151 | |
| 557 | Ubiquitination | HKDLSTSISVSNCQI CCCCCEEEEEECCEE | 4.83 | 27667366 | |
| 605 | Ubiquitination | TGRDVAIKVIDKMRF CCCCEEHHHHHHCCC | 24.33 | - | |
| 615 | Ubiquitination | DKMRFPTKQESQLRN HHCCCCCHHHHHHHH | 52.91 | 29967540 | |
| 626 | Ubiquitination | QLRNEVAILQNLHHP HHHHHHHHHHHCCCC | 4.99 | 27667366 | |
| 730 | Ubiquitination | FARIIGEKSFRRSVV CCEECCCCCHHCCCC | 50.08 | 32142685 | |
| 731 | Phosphorylation | ARIIGEKSFRRSVVG CEECCCCCHHCCCCC | 21.49 | 23401153 | |
| 735 | Phosphorylation | GEKSFRRSVVGTPAY CCCCHHCCCCCCHHH | 19.52 | 29255136 | |
| 739 | Phosphorylation | FRRSVVGTPAYLAPE HHCCCCCCHHHHCHH | 7.98 | 21945579 | |
| 742 | Phosphorylation | SVVGTPAYLAPEVLR CCCCCHHHHCHHHHH | 12.47 | 21945579 | |
| 802 | Phosphorylation | PNPWREISGEAIDLI CCCHHHCCHHHHHHH | 26.31 | 21082442 | |
| 816 | Ubiquitination | INNLLQVKMRKRYSV HHHHHHHHHHHCCCC | 21.74 | - | |
| 822 | Phosphorylation | VKMRKRYSVDKSLSH HHHHHCCCCCCCCCC | 28.07 | 19369195 | |
| 852 | Phosphorylation | ETRIGERYITHESDD HHHHCEEEEECCCCC | 13.08 | 22817900 | |
| 867 | Phosphorylation | ARWEIHAYTHNLVYP CCEEEEEEECCCCCC | 8.38 | 22817900 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KPCD3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KPCD3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SKA2_HUMAN | SKA2 | physical | 21988832 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41 AND SER-44, AND MASSSPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-6; SER-27;SER-30; SER-31; THR-34; SER-41; SER-44; SER-213; SER-216; SER-237;SER-247; SER-252; SER-364; SER-414; SER-415; THR-535; SER-539; THR-542AND SER-543, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27 AND SER-31, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-30; SER-41;SER-44 AND SER-364, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-27; SER-31;SER-37; SER-41; SER-44; SER-213; SER-216; SER-252; SER-364; SER-391;SER-395; THR-535; SER-543; SER-731 AND SER-735, AND MASS SPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-391 AND SER-735, ANDMASS SPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41 AND SER-44, AND MASSSPECTROMETRY. | |